Text Size

Evaluation of Fanconi Syndrome and Cystinosis

This study has been completed.
Sponsor:
Collaborator:
University of California, San Diego
Information provided by:
Office of Rare Diseases (ORD)
ClinicalTrials.gov Identifier:
NCT00004350
First received: October 18, 1999
Last updated: June 23, 2005
Last verified: December 1999
History of Changes
  Purpose

OBJECTIVES:

I. Classify renal tubular defects using clinical and biochemical findings in patients with Fanconi syndrome and cystinosis.


Condition
Cystinosis
Fanconi Syndrome

Study Type: Observational
Study Design: Primary Purpose: Screening

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by Office of Rare Diseases (ORD):

Estimated Enrollment: 12
Study Start Date: October 1999
Detailed Description:

PROTOCOL OUTLINE:

Patients receive a clinical and biochemical evaluation, including a psychometric assessment and molecular, renal, and thyroid studies.

  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria
  • Inherited renal tubular defects, i.e., Fanconi syndrome
  • Fanconi syndrome due to cystinosis eligible
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00004350

Sponsors and Collaborators
National Center for Research Resources (NCRR)
University of California, San Diego
Investigators
Study Chair: Jerry A. Schneider University of California, San Diego
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00004350     History of Changes
Other Study ID Numbers: 199/11911, UCSD-012
Study First Received: October 18, 1999
Last Updated: June 23, 2005
Health Authority: United States: Federal Government

Keywords provided by Office of Rare Diseases (ORD):
Fanconi syndrome
cystinosis
rare disease
renal and genitourinary disorders

Additional relevant MeSH terms:
Cystinosis
Fanconi Syndrome
Fanconi Anemia
Lysosomal Storage Diseases
Metabolism, Inborn Errors
Genetic Diseases, Inborn
Metabolic Diseases
Kidney Diseases
 Urologic Diseases
Renal Tubular Transport, Inborn Errors
Anemia, Hypoplastic, Congenital
Anemia, Aplastic
Anemia
Hematologic Diseases
Bone Marrow Diseases
DNA Repair-Deficiency Disorders

ClinicalTrials.gov processed this record on May 16, 2013